Pain-sensing nerves and immune cells work together to wreak havoc in endometriosis, a painful condition that affects an ...

Merck has announced that the antagonist of the calcitonin gene-related peptide (CGRP) receptor telcagepant has met the primary end points in two Phase III trials to treat migraine, which is ...

Researchers at Harvard Medical School have found that blocking the neuron-released peptide CGRP decreases pain sensitivity and reduces lesion size in endometriosis. Endometriosis is a painful, steroid ...

One class of drugs has already found success in treating the painful, disorienting and common attacks. Excitement is building ...

It blocks the action of a protein called calcitonin gene-related peptide (CGRP). Ubrelvy acts rapidly, often within minutes to hours. Ubrelvy (ubrogepant) is approved for treating migraine with or ...

CGRP is a small snippet of protein made in various places in the body. A messenger molecule that normally clicks into another molecule, called a receptor, on a cell’s surface, CGRP can turn on ...

CGRP is a small protein that circulates at elevated levels during a migraine. People who have chronic migraine consistently have higher levels of CGRP in their system. It's believed that CGRP is ...

They work by blocking the receptor of the CGRP protein. This is found in nerves in the head and neck and is thought to cause inflammation and migraine pain. These drugs have fewer side effects ...

The programming of diabetes in the progeny also occurs in low-protein diet fed mothers. The onset and severity of the diabetes is also sex dependent with early onset and more severe in females ...